هنغاريا - الهنغارية - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

jt pharma - nátrium-foszfát, hypochlorous acid, nátrium-magnézium-fluoroszilikát - külsoleges oldatos spray - kutya, macska

هنغاريا - الهنغارية - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

jt pharma - nátrium-foszfát, hypochlorous acid, nátrium-magnézium-fluoroszilikát - külsoleges oldatos spray - szarvasmarha, juh, kecske, sertés, ló

هنغاريا - الهنغارية - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

jt pharma - nátrium-foszfát, hypochlorous acid, nátrium-magnézium-fluoroszilikát - külsoleges oldatos spray - kutya, macska

الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriparatidot - csontritkulás - kalcium homeosztázis - sondelbay is indicated in adults. osteoporosis kezelése postmenopausában szenvedő nőknél és férfiaknál a repedés fokozott kockázatával. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. a csontritkulás kezelésére kapcsolódó tartós szisztémás kortikoszteroid terápia a nők, mind a férfiak nagyobb a kockázata a törés.

الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - kalcium homeosztázis - a csontritkulás kezelése a posztmenopauzás nőknél a törések kockázatának fokozódásával.

الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatidot - osteoporosis; osteoporosis, postmenopausal - kalcium homeosztázis - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatidot - osteoporosis; osteoporosis, postmenopausal - kalcium homeosztázis - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

هنغاريا - الهنغارية - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

fresenius kabi hungary kft. - sodium glycerophosphate hydrated -

الاتحاد الأوروبي - الهنغارية - EMA (European Medicines Agency)

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - daganatellenes szerek - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.